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Abstract
Background: L-ornithine (L-Orn), is an intermediate metabolite in the urea cycle that plays a significant role in
humans. L-Orn can be obtained from the catalysis of L-arginine (L-Arg) by arginase. The Pichia pastoris expression
system offers the possibility of generating a large amount of recombinant protein. The immobilized enzyme
technology can overcome the difficulties in recovery, recycling and long-term stability that result from the use of
free enzyme.
Methods: The recombinant human arginase I (ARG I) was obtained using an optimized method with the Pichia
pastoris GS115 as the host strain. Chitosan paticles were cross-linked with glutaraldehyde and rinsed exhaustively.
Then the expressed ARG I was immobilized on the crosslinked chitosan particles, and the enzymatic properties of
both the free and immobilized enzymes were evaluated. At last, the immobilized ARG I was employed to catalyze
L-Arg to L-Orn.
Results: The results indicated that these two states both exhibited optimal activity under the same condition of
pH10 at 40 °C. However, the immobilized ARG I exhibited the remarkable thermal and long-term stability as well as
broad adaptability to pH, suggesting its potential for wide application in future industry. After a careful analysis of
its catalytic conditions, immobilized ARG I was employed to catalyze the conversion of L-Arg to L-Orn under
optimal condition of 1 % glutaraldehyde, 1 mM Mn2+, 40 °C, pH10 and an
L-arginine (L-Arg) concentration of 200 g/L, achieving a highly converted content of 149.g/L L-Orn.
Conclusions: In this work, ARG Ι was abundantly expressed, and an efficient, facile and repeatable method was
developed to synthesize high-quality L-Orn. This method not only solved the problem of obtaining a large amount
of arginase, but also provided a promising alternative for the future industrial production of L-Orn.
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Background
L-ornithine (L-Orn) is a non-protein amino acid that
acts as an intermediate metabolite in the urea cycle [1].
It plays a significant role in humans, and is used for the
treatment of the liver diseases, to strengthen the heart
function, for weight loss and to boost immunity. Based
on these versatile advantages, L-Orn is widely applied in
the health care and pharmaceutical industries. Thus, this
field has attracted considerable attention due to the
enormous market [1, 2].
To the best of our knowledge, chemical synthesis, fer-
mentation and enzymatic synthesis are the main methods
used for the preparation of L-Orn. Chemical synthesis is
one of the earliest methods; its drawbacks include the
complex synthesis process and high cost, which have re-
sulted in its gradual elimination [3, 4]. Despite its low cost,
the fermentation method also has several disadvantages;
specifically it is difficult to separate the product from the
fermentation broth due to the complex composition and
because back mutations of the strains are extremely com-
mon [5]. In contrast, the enzymatic synthesis method
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exhibits in several areas, including its facile operation and
easy purification. Moreover, the emergence of immobi-
lized enzyme technology has contributed to its develop-
ment as an economically and ecologically available
biocatalyst method. Therefore, the enzymatic synthesis
method is highly applicable to L-Orn preparation [6, 7].
As the raw material to synthesize L-Orn, L-arginine
(L-Arg), which is able to be produced by a mature and
applicable technology, can be catalyzed by arginase (EC
3.5.3.1; L-arginine amidinohydrolase). Arginase is a key
enzyme in the urea cycle, and catalyses the formation of
urea in the mammalian liver [8, 9]. Arginase is regarded
as a prospective pharmaceutical in the near future for
use in the enzymotherapy of certain types of cancers that
are auxotrophic for arginine; additionally, arginase is being
developed used as a bioanalytical implement to monitor
arginine levels in the blood [10]. Currently, arginase is
mainly extracted from animal livers and exhibits low re-
covery, high cost and viral contamination [11]. Bacteria
such as Bacillus caldovelox, Bacillus anthracis, Helicobac-
ter pylori, Bacillus thuringiensis and Bacillus brevis are an-
other sources of arginase [12–16]. However, these sources
of arginase are inclined to form inclusion bodies and diffi-
cult to purify. Therefore, we employed the more efficient
and facile Pichia pastoris (P. pastoris) expression system
in our work.
First, a suitable expression system was required to
obtain abundant and easily purified arginase. Due to the
impure product obtained using the E. coli expression
system and the high cost and strict culture conditions of
mammalian cell expression systems [17], we selected P.
pastoris as the host for the secretory expression of the
recombinant human arginase Ι (ARG Ι) in this work.
The advantages of this system include the opportunity
to obtain large amounts of protein and a purification
process that is fairly simple and straightforward. Sec-
ond, the free enzyme exhibited a high level of activity,
selectivity and specificity and a lack of long-term
stability, recovery and recyclability, which hampered its
application [18]. This problem appears to have been
solved by the advent of immobilization technology. Out
of the many carriers that have been considered and
studied for fixing enzymes, chitosan was of interest
because it provided most of the characteristics that we
needed. This natural polysaccharide possesses many
superiorities, such as high affinity for proteins, biodegrad-
ability, mechanical stability and diversity of geometrical
configurations; moreover it was fairly suitable for the
chosen biotransformation matrix [19]. Subsequently, we
investigated a method for preparation of chitosan particles
and a fixation procedure for ARG Ι. The optimal conver-
sion conditions were systematically explored, and the re-
usability of the immobilized enzyme was also tested under
these optimum conditions.
Results and discussion
ARG I optimization and synthesis
The ARG Ι sequence is 1032 bp in length, and encodes
a protein of 37.8 kDa. The coding region, apart from a
6 × His–tag, was modified based on the codon usage
bias of P. pastoris and synthesized by overlapping PCR
[20, 21]. Then, the synthetic fragment was cloned into
the pHBM905A vector as a fusion protein with the MF-
alpha leader sequence for secretory expression. The re-
combinant plasmid was named pHBM905A-ARG Ι.
Expression and identification of ARG I
The recombinant plasmid pHBM905A-ARG Ι was trans-
formed into P. pastoris GS115. The positive transformant,
which selected from the MD plate and verified by whole-
cell PCR using primers ARG-1 and ARG-40 (Table 1), was
used for the expression of human arginase I. First, West-
ern blotting with anti-6 × His antibody was used to con-
firm that the main band of approximately 38 kDa was Arg
I (Fig. 1d). Identical amino acid sequences were obtained
from this band by MALDI-TOF-MS identification (Fig. 2),
confirming that the recombinant protein was human argi-
nase I.
The results shown in Fig. 1a represent the superna-
tants collected from the shake-flash culture every 24 h
and separated by12 % SDS-PAGE. The yield of the recom-
binant protein increased to reach a peak of ~121 mg/L at
144 h, after which it declined with the increasing induc-
tion time.
High-density fermentation was applied to the protein
to further enhance the expression quantity. When the
OD600 of the culture reached 300, the supply of glycerol
stopped, and methanol was added to initiate the induc-
tion process. The cell wet weight increased from 180 g/L
during phasing to 456 g/L at the end of methanol induc-
tion. As shown in Fig. 1b, the expression yield of ARG I
reached a maximum concentration of ~1510 mg/L after
84 h of induction. Compared with the shake-flash cul-
ture, the expression quantity via high-density fermenta-
tion increased by approximately 12-fold.
Moreover, the expression quantity of recombinant hu-
man arginase I in our work was greatly improved com-
pared with other recombinant human arginase I
systems, such as Bacillus subtilis [22, 23], Escherichia
coli [24, 25] and Saccharomyces cerevisiae [26].
Purification of ARG I
Despite its high expression quantity, the activity of the
product was restrained; therefore, the enzyme was puri-
fied using a series of methods, including ultrafiltration
and Ni2+-affinity chromatography, to relieve the inhib-
ition of the culture medium [27]. As shown in Table 2
and Fig. 1c, the specific activity of ARG Ι significantly in-
creased from 8.14 to 248.4 U/mg after purification and
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the activity yield of the target protein was raised to
328 %. This result indicated that the elimination of in-
hibitors, including purines, pyrimidines, lysine, ornithine
and urea, could increase the activity and we have suc-
cessfully obtain the pure protein [28, 29]. Therefore, a
high quantity of ARG Ι with superior purity could be
synthesized using our method.
Immobilization yields
Because immobilization yields are a critical parameter in
immobilization technology, a series of experiments were
designed to detect them. The amount of immobilized
protein was determined by subtracting the protein re-
covered in the supernatant from the protein subjected to
immobilization. The immobilization yields were calcu-
lated as the ratio of immobilized protein to the protein
subjected to immobilization. We get the results that
adding 5 g (wet weight) cross-linking particles to 50 ml,
1.2 mg/ml fermentation supernatant, 47.3 % of the en-
zyme would be rinsed out. That is to say about 52.7 % of
the enzyme was immobilized on the chitosan.
Effect of temperature and pH on free and immobilized
ARG I
Considering that free ARG Ι exhibits a lack of long-term
stability, recovery and recyclability that limits its further
Table 1 Primers used in this study for PCR
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application, a crosslinking method for the immobilization
of ARG Ι by chitosan was employed here to improve
its stability. The results of the activity of both free and
immobilized ARG Ι at different temperature and pH
conditions are shown in Fig. 3a and b. The activities
increased and then decreased with increasing temperature
and pH values; the maximum values were achieved at
40 °C and pH 10. Additionally, the relative activity of
the immobilized enzyme was considerably higher than
the soluble enzyme at temperatures higher than 50 °C,
which suggests that immobilization of ARG Ι contrib-
uted to its temperature stability. Moreover, the soluble
ARG Ι exhibited more than 60 % activity from pH 9 to
10, whereas the immobilized enzyme displayed the
most activity from pH 8 to 11. This result indicates
that the immobilized enzyme had a higher adaptability
to pH compared to the free enzyme.
Stability of the free and immobilized ARG I
Both the thermal and long-term stability, which are the
most important parameters for the measurement of the
practicability of enzymes, of the free and immobilized
ARG Ι are illustrated in Fig. 4a and b, respectively. The
immobilized enzyme retained more than 85 % of its ac-
tivity after incubation for 240 min at 40 °C, whereas the
free enzyme lost approximately 30 % of its activity.
Moreover, free ARG Ι was severely attenuated and nearly
inactivated when the temperature rose from 40 to 70 °C.
In contrast, the immobilized enzyme maintained more
than 20 % of its activity at the high temperature. In view
of these results, the immobilized ARG Ι presented re-
markable enhancement in terms of thermal and long-
term stability compared with the free enzyme, which is
meaningful for future industrial applications.
Optimal conditions for bioconversion
Next, we carefully investigated the application of immo-
bilized ARG Ι to catalyse L-Arg into L-Orn. Based on
the series of experiments described above, the immobi-
lized ARG Ι was utilized to synthesize L-Orn under the
optimal conditions of 40 °C and pH 10. To further im-
prove the conversion rate, the concentrations of glutaral-
dehyde and Mn2+ and the reaction time were
systematically studied (Fig. 5a, b and c, respectively). Ac-
cording to the results from Fig. 5a, there was no signifi-
cant change in the activity of the immobilized ARG Ι
when the glutaraldehyde concentration increased from
0.5 to 2.5 %. This result indicates that 1 % glutaralde-
hyde might provide sufficient aldehyde groups on the
surface of the support that are able to bind the enzyme
[30]. The influence of the Mn2+ concentration on the
conversion efficiency is presented in Fig. 5b; the best re-
sult was obtained with the use of 1 mM Mn2+. Finally,
we determined that 200 g/L L-Arg was continually cata-
lysed into L-Orn and reached a peak value close to
100 % after 12 h (Fig. 5c).
Reusability of ARG I
Apart from the high thermal and long-term stability,
the immobilized ARG I also possessed high operational
stability in a batch reactor. The results in Fig. 5d illus-
trate that the activity remained at more than 50 % of its
initial value after 36 cycles. Therefore, the half-life of
the catalyst was determined to be 36 cycles. The results
demonstrate the high operational stability of immobi-
lized ARG Ι.
Fig. 1 SDS-PAGE analysis of ARG I secreted in the cell culture
supernatant. M protein molecular weight marker (the molecular
weight of each band is indicated on left); a Shake-flash culture
supernatants, lane 1–6, culture supernatants collected from 1 to
6 days, lane 7, negative control (P. pastoris bearing the pHBM905A
vector); b High-density fermentation supernatants, lane 1–7,
fermentation supernatants collected from 12 to 84 h; c Purified
enzyme, lane 1, the protein purified with ultrafiltration, lane 2, the
protein purified with Ni2+-affinity chromatography; d Western blot
of ARG I, lane 1, negative control (P. pastoris bearing the pHBM905A
vector), lane 2, positive control (Lipase from Proteus bacillus with
a 6×His–tag), lane 3, the protein purified with Ni2+-affinity
chromatography, lane 4, the protein purified with ultrafiltration
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Identification and transformation quantification of L-Orn
LC-MS measurement was applied to identify the bio-
transformation product (Fig. 6a). The major peak at 133
is the molecular ion (M +H) + that confirms that the
complex is L-Orn. Additionally, HPLC analysis was
employed to quantify the L-Orn content (shown in
Fig. 6b). Using the blank control in Fig. 6b as a refer-
ence, we can determine that the L-Orn peak appears at
4.072 min and that the L-Arg peak appears at 6.850 min.
Based on a series of peak areas of standard samples, the
L-Orn content could be calculated as 149.2 g/L and the
conversion rate was 97.56 %. Thus, our method achieved
a better result compared with previous reports of analo-
gous works [31, 32].
Conclusions
In our study, we report the development of a superior
method for the expression of a high quantity of ARG I
and a highly efficient immobilization method to produce
high-quality L-Orn.
We employed the Pichia pastoris secretory expression
system to express ARG I and the expression yield of it
was as high as ~1510 mg/L. With ultrafiltration and Ni2
+ -affinity chromatography these two steps, the specific
activity of ARG Ι significantly increased from 8.14 to
248.4 U/mg and the recovery of enzyme activity raised
to 328 %. Compared with other expression method, this
has been a huge boost. The immobilized ARG I has been
used to catalyze the conversion of L-Arg to L-Orn under
an optimal condition of 1 % glutaraldehyde, 1 mM Mn2
+, 40 °C, pH10 and L- Arg concentration of 200 g/L,
achieving a highly converted content of 149.2 g/L L-Orn
and a molar conversion of 98 %.
The results suggest that the P. pastoris expression sys-
tem may be a suitable choice for high levels of expres-
sion of various types of proteins and can offer a more
facile and efficient method to obtain pure ARG I. The
technology of immobilizing enzymes on chitosan will be
developed as an economically and ecologically available
biocatalyst method.
Methods
Strains, plasmids and media
P. pastoris GS115, Escherichia coli XL10-gold and the
vector pMD18-T were purchased from Invitrogen (USA).
The expression vector pHBM905A is stored in our labora-
tory [33]. Minimal dextrose (MD), buffered minimal gly-
cerol (BMGY) and buffered minimal methanol (BMMY)
medium were prepared as described in the instructions of
the P. pastoris expression manual from Invitrogen (USA).
Reagents
Chitosan powder was purchased from Sigma (USA), and
the deacetylation degree of it is about 80 %. Glutaralde-
hyde (25 % aqueous solution) was purchased from Sino-
pharm Group Co., Ltd. L-Orn and L-Arg were obtained
from Biosharp (Japan). The anti-6× His monoclonal anti-
body was purchased from California Bioscience (USA). All
other chemicals used in this study were of the highest pur-
ity commercially available.
Optimization and synthesis of ARG I
The DNA coding sequence of arginase I from humans
(GenBank Accession Np_000036) was optimized to
match the codon usage preference of P. pastoris, result-
ing in an identical amino acid sequence with a different












302 2458.3 8.14 100
78.9 8639.6 109.5 351.4
Ni2+-affinity
chromatography
32.5 8073 248.4 328.4
Fig. 2 MALDI-TOF-MS peptide mass fingerprint (PMF) of ARG I generated by in-gel digestion. MALDI-TOF-MS PMF of ARG I
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gene sequence. To synthesize this edited ORF, 40 oligo-
nucleotides (Table 1) were designed with the DNA
Works program (http://helixweb.nih.gov/dnaworks/) for
overlapping PCR. The PCR was performed according to
the method described in previous reports [20, 21]. The
synthesized ARG I fragment was cloned into pMD18-T
for DNA sequencing.
Construction of the recombinant vector for expression in
P. pastoris GS115
The full-length target gene was amplified with primers
p-1 and p-40 (Table 1). Then, the amplified product was
treated with T4 DNA polymerase supplemented with
1 mM dTTP to form overhangs compatible with the
sticky ends of the pHBM905A vector digested with CpoI
and NotI as previously described [33]. These fragments
were ligated and transformed into E. coli XL10-gold to
generate recombinant vectors. The recombinant plasmid
(10 μg) was linearized with SalI and transformed into P.
pastoris GS115 by electroporation (7000 V/cm, 25 μF,
400 × Bio-Rad Gene Pulser, USA) using the Life Tech-
nologies Cell Porator (USA). The positive transformants
were selected on MD plates and confirmed by colony
PCR.
Fig. 4 Effect of the temperature on the stability of the free and immobilized ARG I. a Immobilized enzyme was incubated at 40, 50 and 60 °C for
0–220 min; b Free enzyme was incubated under the same conditions as the immobilized enzyme; The residual activity was determined at 40 °C,
pH 10. In both figure (a) and (b) the activity of the enzyme at 0 min was taken as 100 %
Fig. 3 Effect of the temperature and pH on the free and immobilized ARG I. a Relative activity of the free and immobilized enzymes at different
temperatures ranging from 20 to 70 °C; b Relative activity of the free and immobilized enzymes with different PH values ranging from 6 to 12;
For both the free and the immobilized enzymes in (a) and (b) the maximum activity was taken as 100 %
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Expression of the ARG I and western blot assay
A recombinant P. pastoris GS115 bearing the target
gene in its genome was incubated in 100 ml of BMGY
until the OD600 reached approximately 20. All cells
were harvested by centrifugation and transferred into
50 ml of BMMY. A total of 1 % (v/v) methanol was
added every 24 h to induce the expression of the target
protein. Approximately 1 ml of cell culture was col-
lected every 24 h and centrifuged at 8000 × g for 5 min
to remove cells. After 144 h, an equal volume of each
supernatant was loaded onto a 12 % (w/v) polyacrylamide
gel for SDS-PAGE, followed by staining with Coomassie
brilliant blue G-250. The Western blot assay was imple-
mented using the standard technique. The gels were
electroblotted on polyvinylidenefluoride (PVDF) mem-
branes using Tetra Cell (Bio-Rad, USA). For immune
detection, we used a primary anti-His murine monoclo-
nal antibody (California Bioscience, USA) and a goat
anti-mouse IgG HRP-conjugated secondary antibody
(California Bioscience, USA); the blots were visualized
using the Bio-Rad Gel DOCTM XR+ (USA) imaging
system.
Identification of the recombinant protein by mass
spectrometry
Bands representing the target proteins on the 12 %
(v/v) polyacrylamide gel were excised, and digested
with trypsin overnight at 37 °C. Then identification
was performed with an Ultraflex II MALDI-TOF/TOF
mass spectrometer according to a previous report
[34]. The mass spectrometry results were processed
with the Biotools software and searched against the
Fig. 5 Conversion conditions of the immobilized ARG I reaction. a Relative activity of the arginase catalytic reaction following fixation by chitosan
cross-linking with different concentrations of glutaraldehyde (ranging from 0.5 to 2.5 %), taking the activity of the concentration of 1 % as 100 %;
b The influence of the concentration of Mn2+ in the reaction on the relative transformation efficiency; c The influence of reaction time on the
conversion rate; d Operational stability of immobilized ARG I. All of the reactions were performed at 40 °C and pH10
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National Center for Biotechnology Information data-
base through the Mascot database search engine
(http://www.matrixscience.com).
High-density fermentation
The positive colony strain was inoculated into a flask con-
taining 200 ml of YPD medium and incubated at 28 °C and
250 rpm for 12 h; then, 200 ml of YPD medium was trans-
ferred into 2 l of BMGY medium in a − l BioFlo 2000 fer-
menter (New Brunswick Scientific, USA). The system was
maintained at 301 K, pH 5.8, with 28 % NH4OH and 20 %
dissolved O2. After the carbon source was exhausted, 12 ml
of PTM1 trace salts/l (Invitrogen) with 50 % (v/v) glycerol
was supplied continuously. When the OD600 of the cell cul-
ture reached ~300, methanol with 12 ml of PTM1 trace
salts/l was added to induce the expression of ARG. The pH
and temperature of the system were decreased to 5.5 and
26.3 °C, respectively. Approximately 50 ml of cell culture
was collected every 12 h for SDS-PAGE.
Purification of the ARG I
To purify the target protein, approximately 300 ml of
the fermentation supernatant after induction with metha-
nol for 84 h was centrifuged at 8000 × g for 5 min. The
supernatant was collected, dialysed with a Millipore
10 kDa cut off membrane device at 4 °C to remove ions
and salts and subjected to a Ni2+-affinity chromatography
column as described in the Ni–NTA resin manual from
TransGen Biotechnology (China) to remove other pro-
teins and small peptides. The eluted solutions were dia-
lysed with a Millipore 10 kDa cut-off membrane device.
Enzyme activity assay
The ARG activity assay was performed using the Chi-
nard reaction [35]. An assay reaction mixture was pre-
pared containing 0.1 ml of arginine (0.2 M), 0.88 ml of
bicarbonate buffer (50 mM, pH = 10) and 0.02 ml of a
known protein concentration of purified arginase. First,
each solution was incubated for 5 min at 40 °C in a
water bath. Then, the mixtures were incubated at the
same temperature with gentle shaking for 10 min and
then moved to 100 °C for 5 min to stop the reaction.
The L-ornithine content in the reaction buffer was de-
tected using the Chinard colourimetric assay. In this
study, one unit of enzyme activity was defined as the
amount of enzyme that produces 1 μmol of L-ornithine/
min at 40 °C. Protein contents were measured by Brad-
ford’s method [36].
Particle preparation
Chitosan particles were prepared by the precipitation
method [37]. Chitosan (2 %w/v) was dissolved in an
aqueous solution of acetic acid (2 %w/v) with magnetic
stirring for 1 h. The solution was gradually added into a
violently stirred coagulation liquid (2 M sodium hydrox-
ide and 20 % v/v ethanol) until small white particles ap-
peared. When the chitosan solution had completely
changed into the white particles, they were incubated at
room temperature for 3 h. Then, the obtained white
granules were filtered and washed with distilled water
until neutrality was reached. Cross-linking was performed
by shaking the granules with glutaraldehyde solution at
concentrations ranging from 0.5 to 2.5 % for 4 h; the ex-
cess glutaraldehyde was washed out with distilled water.
Fig. 6 Analysis of biotransformation production. a Identification of L-Orn in the biotransformation by LC-MS; b HPLC analysis of the product of
the reaction
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Enzyme immobilization
Immobilization on chitosan microspheres was accom-
plished by adding 5 g (wet weight) of the cross-linked
particles to 50 ml of the fermentation supernatant. The
mixtures were gently stirred at room temperature for
1 h and then stored in the refrigerator overnight. Finally,
the immobilized enzymes were filtered and washed
with 50 mM bicarbonate buffer (pH 10) until the pro-
tein was no longer detected in the washing solution by
Bradford’s method. The amount of immobilized pro-
tein [38] was determined by subtracting the protein
recovered in the supernatant (P2) from the protein
subjected to immobilization (P1). The immobilization
yields (IY/%) were calculated as the ratio of immobilized
protein (P3) to protein subjected to immobilization (P1)




Characteristics of the free and immobilized enzymes
Optimum temperature: the free enzyme and immobi-
lized derivatives were incubated separately in 0.05 M
bicarbonate buffer at temperatures ranging from 20 to
70 °C. Samples were collected and their activities were
assessed as described above.
Optimum pH: both of the derivatives were incubated
in the following buffers: phosphate buffer (50 mM,
pH 6.0–7.0), Tris-HCl buffer (50 mM, pH 7.0–8.0) and
bicarbonate buffer (50 mM, pH 9.0–11.0) at 40 °C. Their
activities were assessed as described above.
Thermal stability: the two derivatives were incubated
separately in 0.05 M bicarbonate buffer at pH 10.0 and
40, 50, and 60 °C. Periodically, samples were collected
and their residual activities were assessed as described
above.
Optimum conversion conditions
Biotransformation conditions including the temperature,
pH, concentrations of Mn2+ and substrate, amount of the
immobilized enzyme, and reaction time were assessed
according to the methods described in the previous
study [32].
HPLC analysis of samples and identification of the
product using LC-MS
L-arginine and L-ornithine were analysed using an HPLC
system (Agilent1200, USA). First, the underlying solution
was removed and filtered using a 0.22 μm pore size.
The solution in the reaction containing L-arginine and
L-ornithine, was placed into a 1.5 ml centrifuge tube.
For the chromatography, we utilized a C18 column (Luna
5 μ, 100, 150 × 4.6 mm, USA). The mobile phase consisted
of 0.1 mol/L potassium dihydrogen phosphate solution:
acetonitrile solution (v/v = 95:5). HPLC was performed at
40 °C using a detection wavelength of 205 nm, a flow rate
of 1.0 ml/min and an injection volume of 10 μl. The prod-
uct of L-ornithine was identified by LC-MS (Agilent 6224
TOF, USA).
Operational stability of the immobilized enzyme
The operational stability of the immobilized ARG Ι was
assessed using 1 g of derivative containing 82.8U/g of ar-
ginine hydrolysis. The operational conditions were
pH 10.0 and 50 °C. At the end of reaction, the immobi-
lized ARG I was removed from the reaction medium
and washed with bicarbonate buffer to remove any left-
overs. The activities were assessed as described above.
Then, the derivative was introduced into fresh medium
and subjected to another reaction [30].
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